| ［1］ |
中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南（2020版）［J］. 中华皮肤科杂志, 2020,53（2）:81⁃88. doi:10.35541/cjd.20191000.
|
| ［2］ |
中华医学会, 中华医学会杂志社, 中华医学会皮肤性病学分会, 等. 儿童特应性皮炎基层诊疗指南（2023年）［J］. 中华全科医师杂志, 2023,22（1）:8⁃18. doi: 10.3760/cma.j.cn114798⁃20220915⁃00924.
|
| ［3］ |
Suga K, Kiuchi M, Kageyama T, et al. Single⁃cell RNA sequencing of peripheral blood mononuclear cells from Kimura disease patient successfully treated with dupilumab［J］. Allergol Int, 2023,72（4）:610⁃613. doi: 10.1016/j.alit.2023.06.002.
|
| ［4］ |
宋晓婷, 赵作涛, 涂平, 等. 度普利尤单抗治疗木村病1例［J］. 中华皮肤科杂志, 2023,e20220722. doi: 10.35541/cjd.20220722.
|
| ［5］ |
Teraki Y, Terao A. Treatment of Kimura disease with dupilumab［J］. JAMA Dermatol, 2022,158（3）:329⁃330. doi: 10.1001/jamadermatol.2021.5885.
|
| ［6］ |
Bellinato F, Mastrosimini MG, Querzoli G, et al. Dupilumab for recalcitrant Kimura disease［J］. Dermatol Ther, 2022,35（9）:e15674. doi: 10.1111/dth.15674.
|
| ［7］ |
Yang B, Yu H, Jia M, et al. Successful treatment of dupilumab in Kimura disease independent of IgE: a case report with literature review［J］. Front Immunol, 2022,13:1084879. doi: 10.3389/fimmu. 2022.1084879.
|
